Management of hypertension and heart failure in patients with Addison's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2265|82|6|789-792

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.82, Iss.6, 2015-06, pp. : 789-792

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcome of Patients Discharged From a Heart Failure Disease Management Program following Their Clinical and Echocardiographic Recovery

By  

Cardiology, Vol. 131, Iss. 3, 2015-05 ,pp. : 197-202

Karger

Access to resources Recommend Favorite

Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 16, Iss. 2, 2014-02 ,pp. : 143-150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progression from Hypertension to Heart Failure

By  

Cardiology, Vol. 92, Iss. 1, 1999-12 ,pp. : 10-19

Karger

Access to resources Recommend Favorite

Angiotensin II antagonists – therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy

By Ribeiro Artur Beltrame  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 1-16

Informa Healthcare

Access to resources Recommend Favorite

What is the optimal bone‐preserving strategy for patients with Addison's disease?

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 2, 2015-08 ,pp. : 157-161

John Wiley & Sons Inc

Access to resources Recommend Favorite